A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

Completed

Conditions studied: Infertility

In brief

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Key facts

Study ID

NCT01139593

Run by

Virginia Center for Reproductive Medicine

People needed

128

Starts

2010-06-01

Expected to finish

2015-12-01

Last updated by the study team

2015-12-09

Who can join

Age: 21 and older, up to 42. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• women between 21-42 undergoing IVF

You may not qualify if…

• women > 45,
• women with one ovary,
• donor egg,
• surrogacy,
• FET cycles,
• uterine problems,
• large fibroids

Where it is running

• Virginia Center for Reproductive Medicine — Reston, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.